propafenone has been researched along with 5-hydroxypropafenone in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (35.09) | 18.7374 |
1990's | 23 (40.35) | 18.2507 |
2000's | 10 (17.54) | 29.6817 |
2010's | 4 (7.02) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleischer, R; Wiese, M | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Chiba, P; de Laet, R; Ecker, GF; Gasteiger, J; Kaiser, D; Kopp, S; Schulz, J; Terfloth, L | 1 |
Tang, YN; Zhang, WL | 1 |
Axelson, JE; Kerr, CR; Tonn, GR | 1 |
Belloni, M; Bernasconi, R; Cappiello, E; Castel, JM; Giani, P; Landolina, M; Latini, R; Leopaldi, D | 1 |
Follath, F; Ha, HR; Oti-Amoako, K; Vozeh, S | 1 |
Case, CL; Gillette, PC; Hewett, KW; Maheshwari, R; Ravin, RR | 1 |
Leloux, MS; Maes, RA | 1 |
Busato, E; Libardoni, M; Padrini, R; Piovan, D | 1 |
Follath, F; Ha, HR; Haefeli, WE; Taeschner, W; Vozeh, S | 1 |
Frey, B; Plass, H; Probst, P; Pürerfellner, H; Schmidinger, H; Steurer, G; Weber, H | 1 |
Ambrosioni, E; Balducelli, M; Boriani, G; Capucci, A; Frabetti, L; Magnani, B; Marchesini, B; Strocchi, E; Tomasi, L | 1 |
Follath, F; Ha, HR; Haefeli, W; Vlcek, J; Vozeh, S | 1 |
Delgado, C; Tamargo, J; Valenzuela, C | 1 |
Delpón, E; Tamargo, J; Valenzuela, C | 1 |
Adamantidis, MM; Broly, F; Caron, JF; Dupuis, BA; Honore, E; Libersa, CC; Rouet, R; Wajman, A | 1 |
Abbott, FS; Axelson, JE; Chan, GL; Kerr, CR; McErlane, KM | 1 |
Erstad, BL; Furman, C; Hoyer, GL; Kirsten, EB; Marcus, FI; Nolan, PE | 1 |
Funck-Brentano, C; Kroemer, HK; Pavlou, H; Roden, DM; Woosley, RL | 1 |
Brewington, J; Kirsten, EB; Zoble, RG | 1 |
Delgado, C; Tamargo, J; Tejerina, T; Valenzuela, C | 1 |
Barbieri, E; Castello, C; Gerosa, G; Latini, R; Marchi, S; Rossi, R; Sica, A; Zardini, P | 1 |
Hege, HG; Neidlein, R; Wu, M | 1 |
Iansmith, DH; Roden, DM; Siddoway, LA; Thompson, KA; Woosley, RL | 1 |
Benfenati, E; Chen, ZM; Gavinelli, M; Latini, R; Marchi, S; Sica, A | 1 |
Bianchini, C; Ferrario, G; Giani, P; Giudici, V; Landolina, M; Latini, R; Marchi, S; Riva, E | 1 |
Breckwoldt, W; Brode, E; Kripp, U | 1 |
Danilo, P; Forster, M; Malfatto, G; Rosen, MR; Sodowick, B; Zaza, A | 1 |
Cavalli, A; Cazzaniga, MG; Latini, R; Maggioni, AP; Marchi, S; Riva, E; Volpi, A | 1 |
McAllister, CB; Roden, DM; Siddoway, LA; Thompson, KA; Wang, T; Wilkinson, GR; Woosley, RL | 1 |
Kates, RE; Winkle, RA; Yee, YG | 1 |
Brode, E; Hollmann, M; Kripp, U | 1 |
Gries, J; Hofmann, HP; Kreiskott, H; Kretzschmar, R; Müller, CD; Raschack, M; Teschendorf, HJ; von Philipsborn, G | 1 |
Böhm, R; Ellrich, R; Koytchev, R | 1 |
Liu, L; Tang, YN; Wang, ZY; Zhang, WL | 1 |
Kern, R | 1 |
Mizuochi, M; Morita, K; Yamaji, A; Yokoyama, T | 1 |
Boucher, M; Chassaing, C; Hamel, JD; Poirier, JM | 1 |
Giesbrecht, E; Ito, S; Koren, G; Verjee, Z; Woodland, C | 1 |
Axelson, JE; Dodo, H; Freedom, R; Giesbrecht, E; Gow, R; Ito, S; Koren, G; Rosenberg, HC; Tonn, GR; Verjee, Z; Zalzstein, E | 1 |
Belpaire, F; Buylaert, W; Calle, P; Fonck, K; Haenebalcke, C; Hemeryck, A; Jordaens, L | 1 |
Caballero, R; Delpón, E; Franqueza, L; Longobardo, M; Tamargo, J; Valenzuela, C | 1 |
Brandsteterová, E; Kubalec, P | 1 |
Blume, H; Chen, X; Zhong, D | 1 |
Bertucci, C; Bonato, PS; Cesarino, EJ; Lanchote, VL; Pires de Abreu, LR | 1 |
Chow, MS; Fan, C; Lau, CP; Tang, MO; White, CM | 1 |
Cahill, SA; Gross, GJ; Kirshenbaum, LA | 1 |
Chen, X; Gu, J; Jiang, H; Zhong, D | 1 |
Arias, C; Caballero, R; Delpón, E; González, T; Moreno, I; Tamargo, J; Valenzuela, C | 1 |
Cahill, SA; Gross, GJ | 1 |
Bachmakov, I; Eichelbaum, M; Fromm, MF; Hofmann, U; Rekersbrink, S | 1 |
Afshar, M; Thormann, W | 1 |
Dargan, PI; Jones, AL; Ludman, A; Ovaska, H; Spencer, EP; Wood, DM | 1 |
Afshar, M; Rouini, MR | 1 |
Bhatt, C; Desai, N; Ghoghari, A; Jha, A; Patel, H; Shah, S; Srinivas, NR | 1 |
Chi, Z; Ding, L; Li, Y; Liu, R; Shu, C; Wang, K | 1 |
3 trial(s) available for propafenone and 5-hydroxypropafenone
Article | Year |
---|---|
Concentration-effect relations of 5-hydroxypropafenone in normal subjects.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Half-Life; Humans; Male; Posture; Propafenone; Reference Values | 1991 |
Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Random Allocation | 1989 |
A sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode.
Topics: Administration, Oral; Chromatography, Liquid; Drug Stability; Edetic Acid; Humans; Limit of Detection; Linear Models; Propafenone; Reproducibility of Results; Tandem Mass Spectrometry | 2017 |
54 other study(ies) available for propafenone and 5-hydroxypropafenone
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.
Topics: Drug Resistance, Multiple; Drug Resistance, Neoplasm; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Molecular Conformation; Predictive Value of Tests; Propafenone; Quantitative Structure-Activity Relationship; Static Electricity | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Self-organizing maps for identification of new inhibitors of P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Databases, Factual; Drug Resistance; Propafenone; Quantitative Structure-Activity Relationship | 2007 |
[Simultaneous determination of propafenone and its active metabolite in serum by high performance liquid chromatography].
Topics: Anti-Arrhythmia Agents; Humans; Propafenone | 1992 |
In vitro protein binding of propafenone and 5-hydroxypropafenone in serum, in solutions of isolated serum proteins, and to red blood cells.
Topics: Anti-Arrhythmia Agents; Blood Proteins; Cells, Cultured; Erythrocytes; Humans; Lipoproteins; Male; Propafenone; Reference Values; Solutions | 1992 |
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Debrisoquin; Female; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Propafenone | 1992 |
The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.
Topics: Animals; Arrhythmias, Cardiac; Biotransformation; Chromatography, High Pressure Liquid; Male; Myocardial Reperfusion Injury; Propafenone; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Developmental electrophysiologic effects of propafenone and 5-hydroxypropafenone on the canine cardiac Purkinje fiber.
Topics: Age Factors; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Female; Male; Membrane Potentials; Propafenone; Purkinje Fibers | 1991 |
Identification and determination of propafenone and its principal metabolites in human urine using capillary gas chromatography/mass spectrometry.
Topics: Gas Chromatography-Mass Spectrometry; Humans; Propafenone | 1991 |
Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.
Topics: Adult; Animals; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Milk; Pregnancy; Propafenone | 1991 |
Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Propafenone; Ventricular Function, Left | 1991 |
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.
Topics: Administration, Oral; Adult; Aged; Debrisoquin; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phenotype; Propafenone; Time Factors | 1990 |
Nonlinear kinetics of propafenone metabolites in healthy man.
Topics: Biotransformation; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Injections, Intravenous; Male; Propafenone | 1990 |
Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Membrane Potentials; Papillary Muscles; Propafenone | 1987 |
Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Electric Stimulation; Female; Guinea Pigs; Heart; In Vitro Techniques; Male; Membrane Potentials; Papillary Muscles; Propafenone | 1988 |
Comparative electrophysiological effects of propafenone, 5-hydroxy-propafenone, and N-depropylpropafenone on guinea pig ventricular muscle fibers.
Topics: Action Potentials; Animals; Female; Guinea Pigs; Heart; In Vitro Techniques; Male; Membrane Potentials; Papillary Muscles; Propafenone | 1989 |
Determination of 5-hydroxypropafenone in biological fluids by fused-silica capillary gas chromatography using electron-capture detection.
Topics: Chromatography, Gas; Humans; Mass Spectrometry; Propafenone | 1989 |
Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects.
Topics: Adult; Digoxin; Drug Interactions; Half-Life; Humans; Male; Propafenone | 1989 |
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biotransformation; Electrocardiography; Female; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Propafenone; Quinidine | 1989 |
Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Electric Stimulation; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Membrane Potentials; Propafenone | 1987 |
Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery.
Topics: Adult; Cardiac Surgical Procedures; Female; Heart Atria; Humans; Middle Aged; Myocardium; Osmolar Concentration; Propafenone | 1989 |
Synthesis of glucuronides of propafenone and 5-hydroxypropafenone by Sepharose-bound uridine 5'-diphosphoglucuronyltransferase.
Topics: Animals; Chromatography; Chromatography, High Pressure Liquid; Dogs; Enzymes, Immobilized; Glucuronates; Glucuronosyltransferase; Humans; Kinetics; Mass Spectrometry; Propafenone; Uridine Diphosphate Glucuronic Acid | 1988 |
Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.
Topics: Action Potentials; Animals; Biotransformation; Dogs; Heart Conduction System; In Vitro Techniques; Propafenone; Purkinje Fibers | 1988 |
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Topics: Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Propafenone | 1988 |
Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Electrocardiography; Female; Half-Life; Humans; Male; Middle Aged; Propafenone | 1988 |
HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Electrochemistry; Humans; Hydrogen-Ion Concentration; Propafenone | 1988 |
Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Papillary Muscles; Propafenone; Purkinje Fibers; Tachycardia | 1988 |
Distribution of propafenone and its active metabolite, 5-hydroxypropafenone, in human tissues.
Topics: Anti-Arrhythmia Agents; Humans; Male; Middle Aged; Propafenone; Tissue Distribution | 1987 |
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cytochrome P-450 CYP2D6; Debrisoquin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; In Vitro Techniques; Kinetics; Liver; Male; Middle Aged; Mixed Function Oxygenases; Phenotype; Propafenone; Time Factors | 1987 |
Metabolite cumulation during chronic propafenone dosing in arrhythmia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Time Factors | 1985 |
Simultaneous determination of propafenone and 5-hydroxypropafenone in plasma by means of high pressure liquid chromatography.
Topics: Adrenergic beta-Antagonists; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Propafenone; Propiophenones | 1984 |
Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Calcium Channel Blockers; Dogs; Electrocardiography; Electroencephalography; Electrophysiology; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Infarction; Propafenone; Propiophenones; Rabbits; Rats; Rats, Inbred Strains; Tachycardia | 1984 |
Quantitation of R- and S-propafenone and of the main metabolite in plasma.
Topics: Adrenergic beta-Antagonists; Biotransformation; Chromatography, High Pressure Liquid; Humans; Propafenone; Spectrophotometry, Ultraviolet; Stereoisomerism | 1995 |
[Metabolism of propafenone and lidocaine in combination in rat liver supernatant].
Topics: Animals; Drug Synergism; Lidocaine; Liver; Male; Propafenone; Rats; Rats, Wistar | 1994 |
Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
Topics: Adrenergic beta-Antagonists; Chromatography, High Pressure Liquid; Humans; Propafenone; Spectrophotometry, Ultraviolet; Stereoisomerism | 1994 |
Stereoselectivity in the hydroxylation of propafenone enantiomers in mouse hepatic microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Hydroxylation; Kinetics; Male; Mice; Microsomes, Liver; Oxidation-Reduction; Phenobarbital; Propafenone; Stereoisomerism | 1994 |
Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Female; Heart; Heart Conduction System; Hemodynamics; Injections, Intravenous; Male; Propafenone | 1996 |
The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
Topics: Animals; Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Dogs; Drug Interactions; Female; Kidney Tubules; Propafenone; Vinblastine | 1997 |
Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Metabolic Clearance Rate; Propafenone; Tachycardia; Treatment Outcome | 1998 |
ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
Topics: Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Electrocardiography; Female; Half-Life; Heart; Humans; Middle Aged; Poisoning; Propafenone | 1998 |
Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Humans; Kv1.5 Potassium Channel; Mice; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone; Time Factors | 1998 |
Determination of propafenone and its main metabolite 5-hydroxypropafenone in human serum with direct injection into a column-switching chromatographic system.
Topics: Chromatography, High Pressure Liquid; Humans; Propafenone; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1999 |
Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers.
Topics: Adult; Anti-Arrhythmia Agents; Asian People; Glucuronides; Humans; Male; Propafenone | 2000 |
Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase.
Topics: Amylose; Anti-Arrhythmia Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Methylene Chloride; Propafenone; Reproducibility of Results; Solutions; Stereoisomerism | 1999 |
Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; China; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Excitatory Amino Acid Antagonists; Female; Hong Kong; Humans; Male; Middle Aged; Oxidation-Reduction; Propafenone | 2001 |
Transient outward current inhibition by propafenone and 5-hydroxypropafenone in cultured neonatal rat ventricular myocytes.
Topics: Animals; Animals, Newborn; Anti-Arrhythmia Agents; Cells, Cultured; Dose-Response Relationship, Drug; Heart; Heart Ventricles; Humans; Ion Channels; Membrane Potentials; Myocardium; Patch-Clamp Techniques; Propafenone; Rats; Rats, Sprague-Dawley | 2001 |
[Characterization of some glucuronide conjugates by electrospray ion trap mass spectrometry].
Topics: Animals; Glucuronides; Humans; Molecular Structure; Propafenone; Rabbits; Spectrometry, Mass, Electrospray Ionization | 1998 |
Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.
Topics: Animals; Anti-Arrhythmia Agents; Cation Transport Proteins; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone | 2003 |
Propafenone and its metabolites preferentially inhibit IKr in rabbit ventricular myocytes.
Topics: Animals; Anti-Arrhythmia Agents; Heart Ventricles; Male; Myocardium; Myocytes, Cardiac; Potassium Channels; Propafenone; Rabbits | 2004 |
Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.
Topics: Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cyclosporins; Digoxin; Dose-Response Relationship, Drug; Humans; Propafenone; Stereoisomerism | 2005 |
Validated capillary electrophoresis assay for the simultaneous enantioselective determination of propafenone and its major metabolites in biological samples.
Topics: Anti-Arrhythmia Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Electrophoresis, Capillary; Humans; Microsomes, Liver; Propafenone; Reproducibility of Results; Stereoisomerism | 2006 |
Propafenone poisoning--a case report with plasma propafenone concentrations.
Topics: Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Coma; Combined Modality Therapy; Drug Overdose; Electrocardiography; Humans; Male; Middle Aged; Poisoning; Propafenone; Seizures; Shock, Cardiogenic; Spectrophotometry, Ultraviolet; Treatment Outcome | 2010 |
Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
Topics: Adult; Anti-Arrhythmia Agents; Cytochrome P-450 CYP2D6; Female; Humans; Male; Middle Aged; Polymorphism, Genetic; Propafenone; Young Adult | 2017 |
A Sensitive and Rapid LC-MS-MS Method for Simultaneous Determination of Propafenone and Its Active Metabolite 5-Hydroxypropafenone in Human Plasma and Its Application in a Pharmacokinetic Study.
Topics: Adult; Chromatography, Liquid; Humans; Limit of Detection; Linear Models; Propafenone; Reproducibility of Results; Tandem Mass Spectrometry; Young Adult | 2017 |